(Q37169893)

18 August 2017

title

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? (English)

1 reference

18 August 2017

1 reference

1 reference

Kathleen N Moore

1

1 reference

18 August 2017

Monica S Reid

2

1 reference

18 August 2017

Daniel N Fong

3

1 reference

18 August 2017

Tashanna K N Myers

4

1 reference

18 August 2017

Lisa M Landrum

5

1 reference

18 August 2017

Katherine M Moxley

6

1 reference

18 August 2017

Joan L Walker

7

1 reference

18 August 2017

D Scott McMeekin

8

1 reference

18 August 2017

Robert S Mannel

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

20 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

110

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

133-139

1 reference

Splenectomy as part of cytoreductive surgery in ovarian cancer

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Hepatic resection for metachronous metastases from ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Trends in United States ovarian cancer mortality, 1979-1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Ovarian cancer. Survival and treatment differences by age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Management of ovarian cancer in patients older than 80 years of Age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Variations in the Use of Chemotherapy for Elderly Patients With Advanced Ovarian Cancer: A Population-Based Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Treatment of advanced ovarian carcinoma in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Surgical care of elderly women with ovarian cancer: a population-based perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Perioperative morbidity and mortality of gynecological oncologic surgery in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Management of cancer in the older person: a practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2008.03.008

1 reference

18 August 2017

1 reference